Xxera/openscience/retractions

Record #40723

Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats

Zikra Zulfiqar, Fawad Ali Shah, Shagufta Shafique, Abdullah Alattar, Tahir Ali, Arooj Mohsin Alvi, Sajid Rashid, Shupeng Li

Journal

Journal of Inflammation Research

Publisher

Taylor and Francis - Dove Press

Original paper date

Dec 24, 2020

Original DOI

10.2147/JIR.S284471

Country

🇨🇦 Canada · 🇨🇳 China · 🇵🇰 Pakistan · 🇸🇦 Saudi Arabia

Institution

Department of Pharmacology, Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan · National Center for Bioinformatics, Quaid-I-Azam University, Islamabad, Pakistan · Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia · Department of Comparative Biology and Experimental Medicine, Faculty of Veterinary Medicine, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada · State Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Shenzhen Graduate School, Peking University, Shenzhen, People’s Republic of China

Open access

No

Article type

Research Article

Broad categories

(B/T) Government (BLS) Biology - Cellular (BLS) Neuroscience (BLS) Toxicology

Citation lifecycle

How this paper is being cited

Pre-retraction

19

Same day

0

Post-retraction

9

% post-retraction

33.3%

~10.2 citations/yr before retraction · ~2.3 citations/yr after

— citing papers

Who is still citing this work

Loading…